CHRS Coherus Oncology, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 5, 2026
$1.16
· of 52w range
· above low
· to high
$1.0952w low
$2.5752w high
Market Cap (MRQ)
$179M
P/E (TTM)
-1.1
EPS (TTM)
$-1.06
Revenue (TTM)
$51M
your badges
52W Range
$1–$3
Analyst Rating
BUY
Price Target
$8
P/E
-1.1
ROE
-146.3%
Net Profit Margin
-259.4%
Your badge strip is empty — pin a metric anywhere on this page.
CHRS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.16
Market Cap (MRQ)
$179M
P/E (TTM)
-1.1
EPS (TTM)
$-1.06
Revenue (TTM)
$51M
ROE (TTM)
-146.3%
52W Range
$1–$3
CHRS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
About Coherus Oncology, Inc. - Common Stock Company overview from Wikipedia
sectorHealthcare
industryBiotechnology
employees144
countryUS
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$42M2016-12-31 → 2025-12-31
EPS$1.432017-12-31 → 2025-12-31
Free Cash Flow·2016-12-31 → 2023-12-31
Net margin-259.4%2016-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | CHRS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -1.15Y avg ≈-0.2 | ≈-0.2 | · | · | |
| P/S (TTM) | 3.55Y avg ≈3.7 | ≈3.7 | 4.9 | Undervalued | |
| P/B (MRQ) | 2.95Y avg ≈1.5 | ≈1.5 | 2.8 | Pricier | |
| Price / Cash Flow | -1.35Y avg ≈-9.3 | ≈-9.3 | · | · | |
| Price / Tangible Book (MRQ) | 4.3 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | CHRS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | -311.6%5Y avg ≈-150.6% | ≈-150.6% | -609.2% | Top tier | |
| EBITDA Margin | -426.4%5Y avg ≈-149.6% | ≈-149.6% | -576.6% | Top tier | |
| Pretax Margin (TTM) | -316.4%5Y avg ≈-148.5% | ≈-148.5% | -233.1% | In line | |
| Net Profit Margin (TTM) | -259.4%5Y avg ≈18.1% | ≈18.1% | -288.3% | Top tier | |
| ROA (TTM) | -41.9%5Y avg ≈-15.6% | ≈-15.6% | -28.9% | Top tier | |
| ROE (TTM) | -146.3%5Y avg ≈60.6% | ≈60.6% | -55.7% | Top tier | |
| ROIC | -296.9%5Y avg ≈-68.8% | ≈-68.8% | -83.9% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | CHRS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 1.85Y avg ≈2.1 | ≈2.1 | 7.9 | Low liquidity | |
| Quick Ratio (MRQ) | 1.65Y avg ≈1.8 | ≈1.8 | 6.1 | Low liquidity | |
| Interest Coverage | -20.15Y avg ≈-9.7 | ≈-9.7 | -42.5 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | CHRS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 59.8%5Y avg ≈-15.0% | ≈-15.0% | · | · | |
| Revenue CAGR 3Y | -41.5%5Y avg ≈-38.9% | ≈-38.9% | · | · | |
| Revenue CAGR 5Y | -38.4% | · | · | · | |
| EPS YoY | 472.0% | · | · | · | |
| Net Income YoY | 489.4% | · | · | · | |
| EPS CAGR 5Y | -2.5% | · | · | · | |
| Net Income CAGR 5Y | 4.9% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | CHRS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.15Y avg ≈0.4 | ≈0.4 | 0.1 | In line | |
| Inventory Turnover | 3.75Y avg ≈2.4 | ≈2.4 | · | · | |
| Receivables Turnover | 0.75Y avg ≈1.5 | ≈1.5 | 3.4 | Weak | |
| Revenue / Employee | ≈$292.9K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-1.7%
Next Report
Nov 04, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 5, 2026 | $-0.13 | $-0.20 | 36.3% |
| March 31, 2026 | May 11, 2026 | $-0.25 | $-0.28 | 10.3% |
| Dec. 31, 2025 | $-0.34 | $-0.35 | 2.9% | |
| Sept. 30, 2025 | $-0.33 | $-0.33 | 0.45% | |
| June 30, 2025 | $-0.34 | $-0.30 | -12.4% | |
| March 31, 2025 | $-0.35 | $-0.24 | -47.9% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $42M | $26M | $257M | $211M | $327M | $476M | $356M | $0 | $2M | $190M | $30M | $31M | |
| Cost of Revenue | $14M | $9M | $159M | $70M | $58M | $38M | $17M | · | · | · | · | · | |
| R&D Expense | $109M | $92M | $109M | $199M | $363M | $143M | $94M | $110M | $162M | $254M | $213M | $78M | |
| SG&A Expense | $101M | $125M | $192M | $198M | $170M | $139M | $137M | $94M | $71M | $52M | $36M | $18M | |
| Operating Expenses | $223M | $226M | $460M | $468M | $590M | $320M | $248M | $204M | $234M | $306M | $249M | $96M | |
| Operating Income | $-181M | $-200M | $-203M | $-257M | $-264M | $156M | $108M | $-204M | $-232M | $-116M | $-219M | $-65M | |
| Interest Expense | $9M | $11M | $41M | $32M | $23M | $21M | $18M | $10M | $10M | $8M | $33.0K | $4M | |
| Interest Income | $7M | $4M | $3M | $2M | $1M | $600.0K | $2M | $1M | · | · | · | · | |
| Other Non-op | $7M | $8M | $5M | $4M | $-283.0K | $554.0K | $3M | $5M | $3M | $-4M | $-5M | $-19M | |
| Pretax Income | $-183M | $-215M | $-238M | $-292M | $-287M | $136M | $93M | $-209M | $-238M | · | · | · | |
| Income Tax | $0 | $0 | $-380.0K | $0 | $0 | $3M | $3M | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $168M | $29M | $-238M | $-292M | $-287M | $132M | $90M | $-209M | $-238M | $-127M | $-223M | $-87M | |
| EPS (Basic) | $1.43 | $0.25 | $-2.53 | $-3.76 | $-3.81 | $1.85 | $1.29 | $-3.22 | $-4.48 | · | · | · | |
| EPS (Diluted) | $1.43 | $0.25 | $-2.53 | $-3.76 | $-3.81 | $1.62 | $1.23 | $-3.22 | $-4.48 | · | · | · | |
| Shares (Basic) | 117,143,457 | 114,553,537 | 94,162,637 | 77,630,020 | 75,449,632 | 71,411,705 | 69,679,916 | 65,034,827 | 53,133,620 | · | 37,125,617 | 8,520,100 | |
| Shares (Diluted) | 117,143,457 | 114,553,537 | 94,162,637 | 77,630,020 | 75,449,632 | 83,491,898 | 73,185,943 | 65,034,827 | 53,133,620 | · | · | · | |
| EBITDA | $-180M | $-110M | $-200M | $-257M | $-264M | $156M | $108M | $-204M | $-232M | $-116M | $-219M | $-64M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $89M | $126M | $103M | $64M | $417M | $541M | $178M | $72M | $127M | $125M | $158M | $150M | |
| Short-term Investments | $83M | · | $15M | $128M | · | · | $0 | $0 | · | · | · | · | |
| Receivables | $18M | $111M | $261M | $110M | $123M | $157M | $142M | $0 | · | $2M | $2M | $2M | |
| Inventory | $3M | $4M | $63M | $39M | $38M | $44M | $10M | $2M | · | · | · | · | |
| Prepaid Expense | $6M | $10M | $11M | $23M | $11M | $6M | $5M | $2M | $18M | $32M | $35M | $20M | |
| Other Current Assets | · | · | · | · | · | · | · | $83.0K | $142.0K | $3M | $3M | $2M | |
| Current Assets | $207M | $342M | $476M | $381M | $602M | $767M | $343M | $84M | $145M | $161M | $197M | $179M | |
| PP&E (Net) | $1M | $3M | $5M | $9M | $8M | $10M | $6M | $7M | $13M | $11M | $11M | $4M | |
| PP&E (Gross) | · | · | · | · | · | · | $22M | $20M | $23M | $17M | $14M | $6M | |
| Accum. Depreciation | · | · | · | $4M | $4M | $3M | $16M | $13M | $10M | $6M | $4M | $1M | |
| Goodwill | · | · | $943.0K | $943.0K | $900.0K | $943.0K | $943.0K | $943.0K | $943.0K | $943.0K | $943.0K | $943.0K | |
| Intangibles | $20M | $25M | $42M | $6M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Other Non-current Assets | $4M | $6M | $10M | $9M | $10M | $13M | $362.0K | $14.0K | $13.0K | $2M | $146.0K | $50.0K | |
| Total Assets | $258M | $449M | $630M | $481M | $679M | $842M | $409M | $99M | $163M | $178M | $212M | $187M | |
| Accounts Payable | $10M | $28M | $35M | $12M | $16M | $15M | $26M | $15M | $15M | $20M | $26M | $9M | |
| Accrued Liabilities | $20M | $60M | $105M | $50M | $48M | $27M | $17M | $7M | $7M | $28M | $24M | $11M | |
| Current Liabilities | $140M | $283M | $332M | $139M | $165M | $146M | $115M | $33M | $28M | $56M | $106M | $52M | |
| Capital Leases | $1M | $3M | $5M | $4M | $7M | $9M | $10M | $0 | · | · | · | · | |
| Deferred Tax | $1M | $1M | $1M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $20M | $29M | $13M | $3M | $750.0K | $1M | $0 | $2M | $2M | $2M | $2M | $347.0K | |
| Total Liabilities | $197M | $581M | $823M | $618M | $582M | $561M | $304M | $138M | $132M | $159M | $219M | $120M | |
| Long-term Debt | · | · | · | · | · | · | $74M | $0 | · | · | · | · | |
| Common Stock | $12.0K | $12.0K | $11.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $6.0K | $5.0K | $4.0K | $3.0K | |
| Paid-in Capital | $1.44B | $1.42B | $1.39B | $1.20B | $1.15B | $1.04B | $1.00B | · | · | · | · | · | |
| Retained Earnings | $-1.38B | $-1.55B | $-1.58B | $-1.34B | $-1.05B | $-763M | $-895M | $-985M | $-775M | $-537M | $-410M | $-187M | |
| AOCI | $-195.0K | $-275.0K | $-248.0K | $-249.0K | $-270.0K | $-270.0K | $-558.0K | $-282.0K | $-750.0K | $-630.0K | $-401.0K | $-525.0K | |
| Stockholders' Equity | $61M | $-132M | $-193M | $-137M | $98M | $281M | $105M | $-39M | $31M | $19M | $-6M | $67M | |
| Liabilities + Equity | $258M | $449M | $630M | $481M | $679M | $842M | $409M | $99M | $163M | $178M | $212M | $187M | |
| Shares Outstanding | 121,154,925 | 115,614,548 | 112,215,260 | 78,851,516 | 76,930,096 | 72,513,348 | 70,366,661 | 68,302,681 | 59,840,467 | 45,808,163 | 39,005,589 | 33,257,978 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $2M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $674.0K | |
| Stock-based Comp | $17M | $28M | $43M | $51M | $51M | $38M | $34M | $35M | $33M | $27M | $17M | $11M | |
| Deferred Tax | · | · | $-380.0K | · | · | · | $0 | $0 | $0 | · | · | · | |
| Amort. of Intangibles | $3M | $3M | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | · | · | · | · | · | · | · | · | $4M | · | · | · | |
| Other Non-cash | $-325M | $-79M | $17M | · | · | · | · | · | · | · | · | $51M | |
| Operating Cash Flow | $-139M | $-20M | $-175M | $-241M | $-37M | $154M | $28M | $-159M | $-200M | $-253M | $-108M | $-24M | |
| CapEx | · | · | $286.0K | $2M | $1M | $7M | $2M | $789.0K | $5M | $7M | $6M | $3M | |
| Investing Cash Flow | $375M | $230M | $145M | $-167M | $-138M | $-14M | $-13M | $-1M | $-4M | $-7M | · | · | |
| Stock Issued | · | $1M | · | · | $41M | · | · | · | · | · | · | · | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $2.0K | |
| Net Stock Activity | · | · | · | · | $41M | · | · | · | · | · | · | $-2.0K | |
| Financing Cash Flow | $-274M | $-187M | $70M | $54M | $52M | $224M | $89M | $105M | $207M | $226M | · | · | |
| Net Change in Cash | $-37M | $23M | $39M | $-354M | $-124M | $364M | $105M | $-55M | $2M | $-33M | $8M | $111M | |
| Taxes Paid | $36.0K | $-114.0K | $-118.0K | $40.0K | $1M | · | $2M | $0 | $0 | · | · | · | |
| Free Cash Flow | · | · | $-175M | $-243M | $-39M | $147M | $27M | $-160M | $-205M | $-259M | $-114M | $-27M | |
| Levered FCF | · | · | $-216M | $-276M | $-62M | $126M | $9M | · | · | · | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -429.5% | -41.8% | -79.0% | -121.7% | -80.8% | 32.9% | · | · | -14918.8% | -61.0% | -729.2% | -207.9% | |
| Net Margin | 398.4% | 10.7% | -92.5% | -138.2% | -87.9% | 27.8% | · | · | -15306.6% | -67.0% | -743.2% | -280.1% | |
| Pretax Margin | -434.2% | 10.7% | -92.6% | -138.2% | -87.9% | 28.5% | · | · | · | · | · | · | |
| EBITDA Margin | -426.4% | -41.1% | -77.8% | -121.7% | -80.8% | 32.9% | · | · | -14918.8% | -61.0% | -729.2% | -205.8% | |
| ROA | 47.5% | 5.3% | -42.9% | -50.3% | -37.8% | 21.1% | 35.3% | -159.8% | -139.7% | -65.2% | -111.7% | -74.3% | |
| ROE | 185.8% | -25.9% | 145.5% | 248.8% | -251.3% | 49.3% | 177.5% | 1598.2% | -930.7% | -1778.5% | -736.9% | 575.6% | |
| ROIC | -296.9% | · | 104.9% | 186.9% | -270.0% | 54.2% | 99.2% | · | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.2 | 1.4 | 2.7 | 3.6 | 5.3 | 3.0 | 2.5 | 5.1 | 2.9 | 1.9 | 3.5 | |
| Quick Ratio | 1.4 | 0.8 | 1.1 | 2.2 | 3.3 | 4.8 | 2.8 | 2.2 | 4.5 | 2.2 | 1.5 | 3.0 | |
| Interest Coverage | -20.1 | -4.1 | -5.0 | -7.9 | -11.5 | 7.4 | 6.1 | -21.1 | -24.3 | -14.5 | -6638.4 | -16.6 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.5 | 0.5 | 0.4 | 0.4 | 0.8 | · | 0.0 | 0.0 | 1.0 | 0.2 | 0.3 | |
| Inventory Turnover | 3.7 | 1.8 | 3.1 | 1.8 | 1.4 | 1.4 | · | · | · | · | · | · | |
| Receivables Turnover | 0.7 | 1.4 | 1.4 | 1.8 | 2.3 | 3.2 | · | · | · | 111.2 | 15.1 | 23.1 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.50 | $-1.14 | $-1.72 | $-1.74 | $1.27 | $3.87 | $1.50 | $-0.56 | $0.53 | $0.53 | $-0.19 | $2.01 | |
| Revenue / Share | $0.36 | $2.32 | $2.73 | $2.72 | $4.33 | $5.70 | · | · | · | · | · | · | |
| Cash Flow / Share | $-1.18 | $-0.18 | $-1.86 | $-3.11 | $-0.50 | $1.85 | $0.39 | · | · | · | · | · | |
| Cash / Share | $0.73 | $1.09 | $0.92 | $0.81 | $5.42 | $7.46 | $2.52 | $1.06 | $2.12 | $3.20 | $4.76 | $4.52 | |
| EPS (TTM) | $1.43 | $0.25 | $-2.53 | $-3.76 | $-3.81 | $1.62 | $1.23 | $-3.22 | $-4.48 | $-3.43 | · | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 59.8% | -89.7% | 21.9% | -35.4% | -31.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -41.5% | -56.8% | -18.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -38.4% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 472.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -2.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 489.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 4.9% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $42M | $26M | $257M | $211M | $327M | $476M | $356M | $0 | $2M | $190M | $30M | $31M | |
| Net Income TTM | $168M | $29M | $-238M | $-292M | $-287M | $132M | $90M | $-209M | $-238M | $-127M | $-223M | $-87M | |
| Market Cap | $172M | $160M | $374M | $625M | $1.23B | $1.26B | $1.27B | $618M | $527M | $1.10B | $764M | $543M | |
| P/E | 1.0 | 5.5 | -1.3 | -2.1 | -4.2 | 10.7 | 14.6 | -2.8 | -2.0 | -8.2 | · | · | |
| P/S | 4.1 | 6.0 | 1.5 | 3.0 | 3.8 | 2.6 | 3.6 | · | 338.4 | 5.8 | 25.4 | 17.4 | |
| P/B | 2.8 | -1.2 | -1.9 | -4.5 | 12.6 | 4.5 | 12.0 | -16.0 | 16.5 | 53.5 | -123.0 | 8.1 | |
| P / Tangible Book | 4.2 | · | · | · | 13.2 | 4.5 | · | · | · | · | · | · | |
| P / Cash Flow | -1.2 | -7.8 | -2.1 | -2.6 | -32.8 | 8.2 | 44.7 | -3.9 | -2.6 | -4.3 | -7.1 | -22.7 | |
| P / FCF | · | · | -2.1 | -2.6 | -31.7 | 8.6 | 47.8 | -3.9 | -2.6 | -4.2 | -6.7 | -20.3 | |
| Earnings Yield | 100.7% | 18.1% | -76.0% | -47.5% | -23.9% | 9.3% | 6.8% | -35.6% | -50.9% | -12.2% | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14M | $12M | $13M | $12M | $10M | $8M | $8M | $6M | $10M | $2M | $92M | $75M | $59M | $32M | $45M | $45M | |
| Cost of Revenue | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | $1M | $85M | $33M | $25M | $17M | $14M | $35M | |
| R&D Expense | $21M | $22M | $31M | $27M | $26M | $24M | $21M | $22M | $21M | $28M | $26M | $26M | $23M | $34M | $29M | $46M | |
| SG&A Expense | $21M | $23M | $24M | $25M | $26M | $26M | $30M | $28M | $28M | $40M | $49M | $48M | $45M | $49M | $54M | $45M | |
| Operating Expenses | $47M | $48M | $59M | $56M | $56M | $53M | $53M | $53M | $50M | $70M | $160M | $107M | $93M | $100M | $97M | $126M | |
| Operating Income | $-32M | $-36M | $-46M | $-44M | $-45M | $-45M | $-45M | $-47M | $-40M | $-68M | $-69M | $-32M | $-35M | $-68M | $-51M | $-80M | |
| Interest Expense | $2M | $2M | $2M | $2M | $2M | $2M | $727.0K | $3M | $4M | $3M | $11M | $10M | $10M | $10M | $9M | $8M | |
| Other Non-op | $1M | $1M | $2M | $2M | $3M | $187.0K | $1M | $2M | $1M | $3M | $-129.0K | $2M | $2M | $2M | $2M | $1M | |
| Pretax Income | $-33M | $-37M | $-46M | $-45M | $-45M | $-47M | $-45M | $-48M | $-55M | $-68M | $-80M | $-40M | $-43M | $-76M | $-59M | $-87M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | $0 | $-380.0K | · | · | · | · | |
| Net Income | $-21M | $-38M | $-38M | $-36M | $298M | $-57M | $-51M | $-11M | $-13M | $103M | $-80M | $-40M | $-43M | $-76M | $-59M | $-87M | |
| EPS (Basic) | $-0.13 | $-0.28 | $-0.34 | $-0.31 | $2.57 | $-0.49 | $-0.46 | $-0.09 | $-0.11 | $0.91 | $-0.67 | $-0.41 | $-0.49 | $-0.96 | $-0.76 | $-1.11 | |
| EPS (Diluted) | $-0.13 | $-0.28 | $-0.34 | $-0.31 | $2.57 | $2.57 | $-0.46 | $-0.09 | $-0.11 | $0.91 | $-0.67 | $-0.41 | $-0.49 | $-0.96 | $-0.76 | $-1.11 | |
| Shares (Basic) | 154,816,912 | 136,398,303 | · | 116,229,170 | 116,077,710 | 115,857,780 | · | 115,210,091 | 114,819,965 | 112,749,306 | · | 97,738,509 | 87,269,614 | 79,268,853 | · | 77,746,895 | |
| Shares (Diluted) | 154,816,912 | 136,398,303 | · | 116,229,170 | 116,077,710 | 116,077,710 | · | 115,210,091 | 114,819,965 | 112,749,306 | · | 97,738,509 | 87,269,614 | 79,268,853 | · | 77,746,895 | |
| EBITDA | $-32M | $-36M | · | $-44M | $-45M | $-45M | · | $-6M | $-20M | $-42M | · | $-31M | $-34M | $-68M | · | $-80M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $83M | $115M | $89M | $103M | $217M | $82M | $126M | $98M | $159M | $260M | $103M | $80M | $73M | $16M | $64M | $287M | |
| Short-term Investments | $22M | $52M | $83M | $88M | $21M | · | · | · | · | · | $15M | $51M | $72M | $112M | · | · | |
| Receivables | $14M | $22M | $18M | $9M | $5M | $60M | $111M | $168M | $175M | $252M | $261M | $217M | $141M | $101M | · | $91M | |
| Inventory | $6M | $5M | $3M | $2M | $5M | $4M | $4M | $48M | $62M | $62M | $63M | $67M | $64M | $49M | · | $28M | |
| Prepaid Expense | $5M | $9M | $6M | $9M | $12M | $16M | $10M | $14M | $14M | $14M | $11M | $16M | $18M | $21M | · | $22M | |
| Current Assets | $134M | $206M | $207M | $461M | $380M | $310M | $342M | $369M | $558M | $627M | $476M | $444M | $385M | $316M | · | $448M | |
| PP&E (Net) | · | · | $1M | $2M | $2M | $2M | $3M | $3M | $3M | $4M | $5M | $6M | $7M | $8M | · | $10M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | $900.0K | · | · | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | $943.0K | $943.0K | · | · | · | · | |
| Intangibles | $19M | $19M | $20M | $21M | $23M | $24M | $25M | $25M | $27M | $28M | $42M | $17M | · | · | · | · | |
| Other Non-current Assets | $3M | $4M | $4M | $4M | $5M | $6M | $6M | $7M | $8M | $9M | $10M | $8M | $8M | $8M | · | $10M | |
| Total Assets | $191M | $266M | $258M | $517M | $439M | $371M | $449M | $505M | $675M | $764M | $630M | $584M | $470M | $402M | · | $551M | |
| Accounts Payable | $13M | $11M | $10M | $25M | $38M | $41M | $28M | $22M | $77M | $38M | $35M | $37M | $29M | $23M | · | $10M | |
| Accrued Liabilities | $15M | $15M | $20M | $13M | $14M | $46M | $60M | $61M | $61M | $116M | $105M | $67M | $42M | $32M | · | $86M | |
| Current Liabilities | $76M | $132M | $140M | $372M | $264M | $255M | $283M | $296M | $463M | $538M | $332M | $240M | $169M | $123M | · | $171M | |
| Capital Leases | $459.0K | · | $1M | · | · | · | $3M | · | · | · | $5M | · | · | · | · | · | |
| Deferred Tax | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | · | · | · | |
| Other Non-current Liabilities | $18M | $17M | $18M | $18M | $17M | $31M | $29M | $29M | $28M | $3M | $13M | $4M | $102.0K | $102.0K | · | $102.0K | |
| Total Liabilities | $130M | $187M | $197M | $429M | $320M | $555M | $581M | $593M | $759M | $845M | $823M | $717M | $644M | $599M | · | $648M | |
| Common Stock | $15.0K | $15.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $11.0K | $11.0K | $11.0K | $9.0K | $8.0K | · | $7.0K | |
| Paid-in Capital | $1.50B | $1.50B | $1.44B | $1.43B | $1.43B | $1.42B | $1.42B | $1.41B | $1.41B | $1.40B | $1.39B | $1.37B | $1.29B | $1.22B | · | $1.19B | |
| Retained Earnings | $-1.44B | $-1.42B | $-1.38B | $-1.35B | $-1.31B | $-1.61B | $-1.55B | $-1.50B | $-1.49B | $-1.48B | $-1.58B | $-1.50B | $-1.46B | $-1.42B | · | $-1.28B | |
| AOCI | $-281.0K | $-268.0K | $-195.0K | $-203.0K | $-275.0K | $-275.0K | $-275.0K | $-275.0K | $-272.0K | $-272.0K | $-248.0K | $-265.0K | $-297.0K | $-278.0K | · | $-270.0K | |
| Stockholders' Equity | $61M | $79M | $61M | $88M | $120M | $-183M | $-132M | $-88M | $-84M | $-82M | $-193M | $-134M | $-175M | $-197M | $-137M | $-97M | |
| Liabilities + Equity | $191M | $266M | $258M | $517M | $439M | $371M | $449M | $505M | $675M | $764M | $630M | $584M | $470M | $402M | · | $551M | |
| Shares Outstanding | 154,470,363 | 154,217,609 | 121,154,925 | 116,236,018 | 116,222,726 | 115,907,216 | 115,614,548 | 115,213,407 | 115,198,655 | 113,496,854 | 112,215,260 | 109,113,046 | 94,442,014 | 80,488,296 | 78,851,516 | 77,770,593 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $862.0K | $881.0K | $300.0K | $300.0K | $300.0K | $400.0K | $100.0K | $400.0K | $500.0K | $600.0K | $700.0K | $800.0K | $800.0K | $900.0K | $1M | $900.0K | |
| Stock-based Comp | $3M | $2M | $3M | $3M | $5M | $5M | $6M | $7M | $7M | $7M | $11M | $10M | $10M | $12M | $12M | $12M | |
| Amort. of Intangibles | $600.0K | $600.0K | $600.0K | $700.0K | $600.0K | $700.0K | $700.0K | $1M | $700.0K | $900.0K | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | $25M | · | · | · | $-158M | · | · | · | · | · | · | |
| Operating Cash Flow | $-62M | $-58M | $-20M | $-46M | $-47M | $-26M | $29M | $-62M | $60M | $-47M | $-13M | $-54M | $-39M | $-69M | $-100M | $-37M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | $0 | $100.0K | $152.0K | · | $457.0K | |
| Investing Cash Flow | $30M | $31M | $-3M | $-67M | $463M | $-17M | $-542.0K | $444.0K | $28M | $203M | $35M | $51M | $41M | $18M | $-130M | $-457.0K | |
| Stock Issued | $0 | $54M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $54M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $144.0K | $54M | $8M | $2.0K | $-282M | $-264.0K | $231.0K | $-167.0K | $-188M | $887.0K | $366.0K | $11M | $54M | $4M | $7M | $49M | |
| Net Change in Cash | $-32M | $26M | $-14M | $-114M | $134M | $-44M | $28M | $-62M | $-101M | $157M | $23M | $7M | $57M | $-47M | $-223M | $11M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-69M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -226.0% | -293.7% | · | -383.1% | -443.6% | -597.9% | · | -9.0% | -31.6% | -55.2% | · | -42.9% | -58.8% | -208.9% | · | -177.1% | |
| Net Margin | -144.2% | -311.4% | · | -307.1% | 2903.9% | -744.4% | · | -15.2% | -19.9% | 133.5% | · | -53.2% | -73.0% | -233.5% | · | -190.8% | |
| Pretax Margin | -233.1% | -300.0% | · | -384.7% | -437.5% | -623.7% | · | -15.2% | -19.9% | 133.5% | · | -53.7% | -73.0% | -233.5% | · | -190.8% | |
| EBITDA Margin | -226.0% | -293.7% | · | -380.6% | -440.7% | -592.6% | · | -8.5% | -30.8% | -54.4% | · | -41.9% | -57.5% | -208.9% | · | -177.1% | |
| ROA | -6.5% | -12.0% | · | -7.0% | 53.4% | -10.0% | · | -2.0% | -2.3% | 17.6% | · | -7.0% | -8.4% | -15.2% | · | -13.4% | |
| ROE | -22.8% | 73.1% | · | 35709.6% | 1667.3% | 42.6% | · | 9.7% | 10.0% | -73.9% | · | 34.4% | 43.4% | 82.3% | · | -515.4% | |
| ROIC | · | · | · | · | · | · | · | · | · | · | · | 23.7% | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 1.6 | · | 1.2 | 1.4 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.9 | 2.3 | 2.6 | · | 2.6 | |
| Quick Ratio | 1.6 | 1.4 | · | 0.5 | 0.9 | 0.6 | · | 0.9 | 0.7 | 1.0 | · | 1.5 | 1.7 | 1.9 | · | 2.2 | |
| Interest Coverage | -13.9 | -16.5 | · | -19.1 | -20.0 | -21.1 | · | -1.2 | -3.8 | -3.8 | · | -3.1 | -3.5 | -7.0 | · | -10.7 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.8 | 0.9 | · | 0.1 | 0.1 | 0.1 | · | 0.4 | 0.4 | 0.6 | · | 0.7 | 0.5 | 0.4 | · | 1.1 | |
| Receivables Turnover | 1.5 | 0.3 | · | 0.1 | 0.1 | 0.0 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.3 | · | 0.4 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.39 | $0.51 | · | $0.76 | $1.03 | $-1.58 | · | $-0.76 | $-0.73 | $-0.72 | · | $-1.22 | $-1.85 | $-2.44 | · | $-1.25 | |
| Revenue / Share | $0.09 | $0.09 | · | $0.10 | $0.09 | $0.07 | · | $0.61 | $0.57 | $0.61 | · | $0.76 | $0.67 | $0.41 | · | $0.58 | |
| Cash Flow / Share | · | $-0.42 | · | · | · | $-0.22 | · | · | · | $-0.37 | · | · | · | $-0.87 | · | · | |
| Cash / Share | $0.54 | $0.75 | · | $0.89 | $1.87 | $0.71 | · | $0.85 | $1.38 | $2.29 | · | $0.74 | $0.77 | $0.20 | · | $3.69 | |
| EPS (TTM) | $-1.06 | $1.64 | · | $4.37 | $4.59 | $1.91 | · | $0.04 | $-0.28 | $-0.66 | · | $-2.62 | $-3.32 | $-3.48 | · | $-3.55 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $51M | $47M | · | $37M | $32M | $32M | · | $110M | $179M | $227M | · | $211M | $182M | $183M | · | $239M | |
| Net Income TTM | $-132M | $186M | · | $155M | $180M | $-131M | · | $-450.0K | $-29M | $-59M | · | $-217M | $-264M | $-271M | · | $-279M | |
| Market Cap | $216M | $261M | · | $191M | $85M | $94M | · | $120M | $199M | $271M | · | $408M | $403M | $551M | · | $747M | |
| P/E | -1.3 | 1.0 | · | 0.4 | 0.2 | 0.4 | · | 26.0 | -6.2 | -3.6 | · | -1.4 | -1.3 | -2.0 | · | -2.7 | |
| P/S | 4.2 | 5.6 | · | 5.1 | 2.7 | 3.0 | · | 1.1 | 1.1 | 1.2 | · | 1.9 | 2.2 | 3.0 | · | 3.1 | |
| P/B | 3.6 | 3.3 | · | 2.2 | 0.7 | -0.5 | · | -1.4 | -2.4 | -3.3 | · | -3.1 | -2.3 | -2.8 | · | -7.7 | |
| P / Tangible Book | 5.1 | 4.4 | · | 2.8 | 0.9 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | -4.5 | · | · | · | -3.6 | · | · | · | -5.8 | · | · | · | -8.0 | · | · | |
| Earnings Yield | -75.7% | 97.0% | · | 266.5% | 627.9% | 236.7% | · | 3.9% | -16.2% | -27.6% | · | -70.0% | -77.8% | -50.9% | · | -36.9% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $42M | $26M | $257M | $211M | $327M |
| Operating Margin % | -429.5% | -41.8% | -79.0% | -121.7% | -80.8% |
| Net Income | $168M | $29M | $-238M | $-292M | $-287M |
| Diluted EPS | $1.43 | $0.25 | $-2.53 | $-3.76 | $-3.81 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.2 | 1.4 | 2.7 | 3.6 |
| Quick Ratio | 1.4 | 0.8 | 1.1 | 2.2 | 3.3 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | · | · | $-175M | $-243M | $-39M |
Institutional owners (13F) 161 filers · $91.7M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
161
Value held
$91.7M
New positions
12
Exited positions
19
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 12 (-32 vs prior Q) | 19 (+12 vs prior Q) | 61 (+14 vs prior Q) | 45 (+8 vs prior Q) | -1.8M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $16,804,642 | 12,003,316 | 18.34% | Shares |
| VANGUARD GROUP INC | $14,241,029 | 10,028,893 | 15.54% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $8,329,286 | 5,949,490 | 9.09% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $5,161,010 | 3,685,567 | 5.63% | Shares |
| SAMSARA BIOCAPITAL, LLC | $4,799,999 | 3,428,571 | 5.24% | Shares |
| Kohlberg Kravis Roberts & Co. L.P. | $4,184,019 | 3,036,076 | 4.57% | Shares |
| STATE STREET CORP | $3,335,227 | 2,382,305 | 3.64% | Shares |
| TWO SIGMA INVESTMENTS, LP | $3,163,177 | 2,259,412 | 3.45% | Shares |
| CM Management, LLC | $2,940,000 | 2,100,000 | 3.21% | Shares |
| Alyeska Investment Group, L.P. | $2,426,528 | 1,733,234 | 2.65% | Shares |
| Hudson Bay Capital Management LP | $2,370,200 | 1,693,000 | 2.59% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $1,862,281 | 1,330,201 | 2.03% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1,719,297 | 1,228,069 | 1.88% | Shares |
| PANAGORA ASSET MANAGEMENT INC | $1,592,255 | 1,137,325 | 1.74% | Shares |
| NORTHERN TRUST CORP | $1,581,259 | 1,129,470 | 1.73% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $1,422,387 | 1,015,991 | 1.55% | Shares |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $1,260,000 | 899,999 | 1.37% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,236,836 | 883,454 | 1.35% | Shares |
| UBS Group AG | $1,064,501 | 760,358 | 1.16% | Shares |
| GOLDMAN SACHS GROUP INC | $842,905 | 602,075 | 0.92% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $788,278 | 563,056 | 0.86% | Shares |
| STRS OHIO | $553,840 | 395,600 | 0.60% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $547,400 | 391,000 | 0.60% | Shares |
| Invesco Ltd. | $495,491 | 353,922 | 0.54% | Shares |
| Bank of New York Mellon Corp | $447,563 | 319,687 | 0.49% | Shares |
| TWO SIGMA ADVISERS, LP | $436,792 | 307,600 | 0.48% | Shares |
| BANK OF AMERICA CORP /DE/ | $423,540 | 302,528 | 0.46% | Shares |
| ALLIANCEBERNSTEIN L.P. | $375,011 | 221,900 | 0.41% | Shares |
| Jefferies Financial Group Inc. | $352,800 | 252,000 | 0.38% | Shares |
| Nuveen, LLC | $351,049 | 250,749 | 0.38% | Shares |
| MORGAN STANLEY | $323,048 | 230,748 | 0.35% | Shares |
| Tyche Wealth Partners LLC | $281,683 | 201,202 | 0.31% | Shares |
| BARCLAYS PLC | $281,601 | 201,143 | 0.31% | Shares |
| IEQ CAPITAL, LLC | $227,294 | 162,353 | 0.25% | Shares |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $223,986 | 159,990 | 0.24% | Shares |
| RHUMBLINE ADVISERS | $199,296 | 142,361 | 0.22% | Shares |
| ENVESTNET ASSET MANAGEMENT INC | $197,218 | 140,870 | 0.22% | Shares |
| PVG ASSET MANAGEMENT CORP | $186,529 | 133,235 | 0.20% | Shares |
| DEUTSCHE BANK AG\ | $178,669 | 127,621 | 0.19% | Shares |
| XTX Topco Ltd | $172,896 | 123,497 | 0.19% | Shares |
| CITADEL ADVISORS LLC | $162,120 | 115,800 | 0.18% | Put option |
| Summit Financial, LLC | $160,805 | 114,861 | 0.18% | Shares |
| WELLS FARGO & COMPANY/MN | $158,064 | 112,903 | 0.17% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $153,478 | 109,627 | 0.17% | Shares |
| Shay Capital LLC | $147,456 | 105,326 | 0.16% | Shares |
| Corient Private Wealth LP | $140,000 | 100,000 | 0.15% | Shares |
| HSBC HOLDINGS PLC | $130,950 | 91,895 | 0.14% | Shares |
| CWM, LLC | $118,876 | 70,341 | 0.13% | Shares |
| MetLife Investment Management, LLC | $110,058 | 78,613 | 0.12% | Shares |
| SEI INVESTMENTS CO | $107,281 | 76,629 | 0.12% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| KKR BIOSIMILAR L.P., KKR BIOSIMILAR GP LLC, KKR FUND HOLDINGS L.P., KKR FUND HOLDINGS GP LIMITED, KKR GROUP HOLDINGS CORP., KKR & CO. INC., KKR MANAGEMENT LLC, HENRY R. KRAVIS, GEORGE R. ROBERTS ×3 filings | Dec. 2, 2019 | · | Initial filing | · | SEC |
| Sofinnova Venture Partners VII, L.P. (“SVP VII”), Sofinnova Management VII, L.L.C. (“SM VII”), Dr. Michael F. Powell (“Powell”), Dr. James I. Healy (“Healy”), Eric P. Buatois (“Buatois”) ×4 filings | Feb. 14, 2018 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 29 insiders · 10 officers · 18 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Dennis M Lanfear | President & CEO | May 29, 2026 A | 1,048,235 | 0 | 0 | $0 |
| Bryan J Mcmichael | Chief Financial Officer | May 29, 2026 A | 133,736 | 0 | 0 | $0 |
| Mcdavid Stilwell | Chief Financial Officer | Dec. 31, 2023 F | 75,305 | 0 | 0 | $0 |
| Jean-Frederic Viret | Chief Financial Officer | Feb. 1, 2021 M | 61,295 | 0 | 0 | $0 |
| Vincent R Anicetti | Chief Operating Officer | July 6, 2021 A | 124,790 | 0 | 0 | $0 |
| Paul Reider | Chief Commercial Officer | Jan. 20, 2025 F | 82,069 | 0 | 0 | $0 |
| Vladimir Vexler | Chief Scientific Officer | March 31, 2023 F | 116,361 | 0 | 0 | $0 |
| Barbara K Finck | Chief Medical Officer | Sept. 10, 2018 M | 37,043 | 0 | 0 | $0 |
| Peter K. Watler | Chief Technical Officer | Feb. 1, 2018 A | 5,900 | 0 | 0 | $0 |
| Alan C. Herman | Chief Scientific Officer | Dec. 15, 2017 A | 50,460 | 0 | 0 | $0 |
| Michael Lee Ryan | Director | June 5, 2026 A | 30,000 | 0 | 0 | $0 |
| Jill O'Donnell-Tormey | Director | June 5, 2026 A | 30,000 | 0 | 0 | $0 |
| Charles W. Newton | Director | June 5, 2026 A | 30,000 | 0 | 0 | $0 |
| Lee Nisley Newcomer | Director | June 5, 2026 A | 30,000 | 0 | 0 | $0 |
| Ali J. Satvat | Director | June 5, 2026 A | 30,000 | 0 | 0 | $0 |
| Rita A Karachun | Director | June 5, 2026 A | 30,000 | 0 | 0 | $0 |
| Mats Wahlstrom | Director | June 5, 2026 A | 30,000 | 0 | 0 | $0 |
| Georgia Erbez | Director | June 12, 2025 A | · | 0 | 0 | $0 |
| Kimberly Jo Tzoumakas | Director | June 3, 2024 A | · | 0 | 0 | $0 |
| Mark Stolper | Director | June 3, 2024 A | · | 0 | 0 | $0 |
| Dr. James I. Healy | Director | Jan. 7, 2022 A | 0 | 0 | 0 | $0 |
| MENDELSON ALAN C | Director | May 21, 2021 A | · | 0 | 0 | $0 |
| Mary T Szela | Director | Jan. 11, 2021 A | 0 | 0 | 0 | $0 |
| Bryan V Lawlis | Director | Jan. 11, 2021 A | · | 0 | 0 | $0 |
| Samuel R Nussbaum MD | Director | Jan. 11, 2021 A | · | 0 | 0 | $0 |
| Christos Richards | Director | Jan. 10, 2020 A | 63,836 | 0 | 0 | $0 |
| August J. Troendle | Director | Feb. 1, 2018 A | 29,994 | 0 | 0 | $0 |
| FMR LLC | · | Aug. 8, 2016 S | 361,594 | 0 | 0 | $0 |
| Daiichi Sankyo Company, LTD | · | Nov. 12, 2014 C | 2,867,426 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 16 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.46% | 88,872 SH | Oct. 1, 2026 | Daily |
| IWC · iShares Trust | 0.04% | 445,148 SH | Sept. 11, 2026 | Daily |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.01% | 10,938 SH | Oct. 1, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 750,573 SH | Aug. 19, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 76,202 SH | Aug. 19, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.01% | 210,687 SH | Oct. 1, 2026 | Daily |
| RSSL · Global X Funds | 0.01% | 62,442 NS | July 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.01% | 3,158,896 SH | Sept. 11, 2026 | Daily |
| IWO · iShares Trust | 0.00% | 436,778 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.00% | 17,030 SH | Sept. 3, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.00% | 15,055 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 1,863,589 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 3,953,617 SH | Aug. 19, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.00% | 49,507 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 7,172 SH | Aug. 19, 2026 | Daily |
| IWN · iShares Trust | · | 737,019 SH | Sept. 11, 2026 | Daily |
CHRS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 12 analysts
BUY
Median target
$8.50
+632.8%
4 33.3%
Strong Buy
6 50.0%
Buy
2 16.7%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
4 analysts · 2026-10-03Mean target $7.75 +568.1%
← Below all targets
Current price $1.16
Low$4.00
Mean$7.75
High$10.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| CHRS | $172M | 1.0 | 59.8% | 398.4% | 185.8% | · |
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | · |
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | · |
| ELDN | $114M | -2.9 | · | · | -69.4% | · |
| PYXS | $72M | -0.9 | -14.2% | -574.5% | -112.9% | · |
| CUE | $29M | -1.1 | 195.8% | -96.9% | -119.3% | · |
| NKTX | $131M | -1.3 | · | · | -31.1% | · |
| CNTN | $112M | -2.7 | · | · | -18.0% | · |
| ORGO | $658M | 34.5 | 17.0% | 6.6% | 13.9% | · |
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | · |
| ALXO | $61M | -0.6 | · | · | -225.0% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 5, 2026